GO
Loading...

WellPoint Inc

More

  • *Yelp shares up in premarket as revenue jumps. Health insurer Cigna Corp reported first-quarter earnings that beat expectations, following similarly positive results from competitors WellPoint Inc and Aetna Inc. Textron Inc's earnings fell from the prior year while revenue was nearly flat.

  • May 1- U.S. health insurer Cigna Corp on Thursday reported a higher-than-expected quarterly profit as medical enrollments increased and it managed costs of its commercial and Medicare customers. The report by Cigna follows big beats by larger competitors WellPoint Inc and Aetna Inc for the first quarter.

  • GOP: Health signups lagging Wednesday, 30 Apr 2014 | 8:20 PM ET

    A report released Wednesday said one-third of people who signed up for health insurance through new federal exchanges hadn't paid their first month's premium.

  • April 30- WellPoint Inc on Wednesday said that its Obamacare exchange business was sustainable so far, echoing comments from another major insurer last week that these new customers have cost as much as expected, not more.

  • WellPoint profit beats as exchanges fall in line Wednesday, 30 Apr 2014 | 11:13 AM ET

    WellPoint reported profit that beat analysts' expectations and said individual exchanges were operating at a profit.

  • April 30- WellPoint Inc, the second-largest U.S. health insurer, on Wednesday reported first-quarter profit that beat analysts' expectations and said that the individual exchanges created under healthcare reform were operating at a profit.

  • Early movers: TWX, GE, AAPL, TWTR & more Wednesday, 30 Apr 2014 | 7:44 AM ET

    Some of the names on the move ahead of the open.

  • April 30- WellPoint Inc, the second-largest U.S. health insurer, said on Wednesday that first-quarter profit fell, largely because of investment spending related to healthcare reform and the higher administrative costs of adding new commercial customers.

  • WellPoint says first-quarter profit fell on reform costs Wednesday, 30 Apr 2014 | 6:14 AM ET

    April 30- WellPoint Inc, the second-largest U.S. health insurer, said on Wednesday that first-quarter profit fell, largely because of investment spending related to healthcare reform and the higher administrative costs of adding new commercial customers.

  • Three things to watch when Wellpoint reports Tuesday, 29 Apr 2014 | 12:25 PM ET
    WellPoint Inc. headquarters stand in Indianapolis, Indiana.

    WellPoint bet big Obamacare, and investors expect the nation's largest provider of Blue Cross plans to report large membership gains.

  • Activists, big pharma & lil' 'Squawkers' deliver Thursday, 24 Apr 2014 | 7:02 PM ET

    What a week on "Squawk Box"! Bill Ackman teams up with Valeant to buy Botox-maker Allergan. Novartis' buying and selling and lil' Squawkers running the show.

  • April 24- Aetna Inc said on Thursday its first few months under Obamacare turned out better than expected as it added new members not only on the exchanges but in its traditional large corporate business.

  • Your first trade for Thursday Wednesday, 23 Apr 2014 | 1:12 PM ET

    The "Fast Money" traders share their final trades of the day.

  • Midday movers: Weibo, Sabre, Goldman Sachs & More Thursday, 17 Apr 2014 | 12:30 PM ET
    Sign for Sabre IPO on Nasdaq board

    Some of Thursday's midday movers:

  • April 17- UnitedHealth Group Inc, the largest U.S. health insurer, said on Thursday it has spent more than $100 million to cover a pricey new hepatitis C drug from Gilead Sciences Inc, a higher cost than it expected by "multiples," sending shares in the sector lower.

  • Aetna, Cramer’s so glad he met ya’! Tuesday, 25 Mar 2014 | 6:25 PM ET

    Does your portfolio leave you feeling a little nauseous? Cramer thinks shares of Aetna could make you feel a lot better.

  • March 21- U.S. lawmakers have asked Gilead Sciences Inc to explain the $84,000 price tag of its new hepatitis C drug Sovaldi, which is encountering resistance from health insurers and state Medicaid programs. Biogen Idec fell 8 percent, Amgen Inc dropped 3 percent and Celgene Corp lost 3.7 percent.

  • March 21- U.S. lawmakers have asked Gilead Sciences Inc to explain the $84,000 price tag of its new hepatitis C drug Sovaldi, which is encountering resistance from health insurers and state Medicaid programs. Biogen Idec fell 6 percent, Amgen Inc dropped 2.5 percent and Celgene Corp was down 2 percent.

  • US STOCKS-Wall St rallies, S&P 500 briefly hits record Friday, 21 Mar 2014 | 10:44 AM ET

    *Nike falls after results, Tiffany rises. Geopolitical issues remained in focus after President Vladimir Putin signed laws completing Russia's annexation of Crimea and investors took fright at a U.S. decision to slap sanctions on his inner circle.

  • *Nike shares fall in premarket after outlook. NEW YORK, March 21- U.S. stock index futures pointed to a slightly higher open on Friday, with major indexes on track for a week of strong gains, though geopolitical concerns remained in view as the tenuous situation in Ukraine continued.